Jocasta Signs UCSF Licensing Agreement to Advance α-klotho for Managing Cognitive Impairment

Expanded agreement builds on the license Jocasta acquired from Unity Biotechnology SCOTTSDALE, Ariz., Aug. 19, 2026 /PRNewswire/ -- Jocasta Neuroscience, Inc., a biotechnology company developing therapeutics to address neurodegenerative diseases, today announced it has entered into a new...